Published in Eur J Neurosci on September 01, 1995
Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch (2010) 2.83
Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology (2010) 2.31
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J (2006) 1.55
The vitamin nicotinamide: translating nutrition into clinical care. Molecules (2009) 1.36
Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology (2011) 0.99
Diabetes mellitus: channeling care through cellular discovery. Curr Neurovasc Res (2010) 0.93
Novel avenues of drug discovery and biomarkers for diabetes mellitus. J Clin Pharmacol (2010) 0.86
Design and synthesis of a siderophore conjugate as a potent PSMA inhibitor and potential diagnostic agent for prostate cancer. Bioorg Med Chem (2007) 0.77
Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo. Neurotox Res (2014) 0.75
Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP, Long-Term Potentiation, and Disrupts Memory Reconsolidation. Neuropsychopharmacology (2017) 0.75
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Two tips for users of Bullard Intubating Laryngoscope. Anesth Analg (1998) 3.32
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
Activation of metabotropic glutamate receptor type 2/3 suppresses transmission at rat hippocampal mossy fibre synapses. J Physiol (1996) 2.34
A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis (2001) 1.99
Cortical dysplasia: an immunocytochemical study of three patients. Neurology (1998) 1.83
(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology (2003) 1.82
Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes. Brain (2004) 1.73
Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum (1998) 1.63
Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol (1995) 1.63
The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci (1986) 1.61
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci (1988) 1.52
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. Leukemia (2011) 1.51
Role of acid and bile reflux in development of specialised intestinal metaplasia in distal oesophagus. Dig Liver Dis (2002) 1.49
Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies. J Neuroimmunol (2007) 1.47
Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol (2009) 1.46
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia (2011) 1.45
Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club. Ital J Gastroenterol Hepatol (1997) 1.45
Further study on pharmacological properties of the cerebellar-induced inhibition of deiters neurones. Exp Brain Res (1970) 1.44
Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci (1996) 1.43
Actions of several anthelmintics and insecticides on rat cortical neurones. Brain Res (1970) 1.41
The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways. Eur J Neurosci (2001) 1.40
Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab (2001) 1.38
Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum Mol Genet (2000) 1.35
Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proc Natl Acad Sci U S A (1986) 1.34
The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today (1999) 1.33
Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci (2001) 1.31
Ipsilateral motor responses to focal transcranial magnetic stimulation in healthy subjects and acute-stroke patients. Stroke (2001) 1.29
Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci (2001) 1.29
Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci (1995) 1.28
A new potent excitant, quisqualic acid: effects on crayfish neuromuscular junction. Neuropharmacology (1974) 1.27
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia (2008) 1.27
The ontogeny of brain receptors for corticotropin-releasing factor and the development of their functional association with adenylate cyclase. J Neurosci (1988) 1.27
Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth (2013) 1.26
Dual modulation of synaptic inhibition by distinct metabotropic glutamate receptors in the rat hippocampus. J Physiol (1995) 1.26
Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. J Neurochem (1986) 1.26
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial. Br J Cancer (2012) 1.26
Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology (2000) 1.24
Band heterotopia: correlation of outcome with magnetic resonance imaging parameters. Ann Neurol (1994) 1.22
Mitotic signaling by beta-amyloid causes neuronal death. FASEB J (1999) 1.21
A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord. Br J Pharmacol (1993) 1.20
Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions. Cancer Res (1997) 1.19
Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology (2005) 1.19
Electrophoretic release of gamma-aminobutyric acid and glutamic acid from micropipettes. Neuropharmacology (1970) 1.18
Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience (2008) 1.17
Differential neuroprotection from human heat shock protein 70 overexpression in in vitro and in vivo models of ischemia and ischemia-like conditions. Exp Neurol (2001) 1.17
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther (1999) 1.17
Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Int J Cancer (2000) 1.16
Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol (2004) 1.14
Ca2+-sensitive isolation of a cortical actin matrix from Dictyostelium amoebae. J Muscle Res Cell Motil (1983) 1.13
Effects of kainic acid analogues on crayfish opener muscle. Neuropharmacology (1976) 1.13
Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci (1998) 1.13
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey. The Italian Ulcer Study Group "GISU". Dig Liver Dis (2001) 1.11
Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci (1996) 1.11
Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J Cereb Blood Flow Metab (2001) 1.10
Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death Differ (2005) 1.10
Increased production of extracellular glutamate by the mitochondrial glutaminase following neuronal death. J Biol Chem (1997) 1.10
Familial schizencephaly associated with EMX2 mutation. Neurology (1997) 1.09
Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol Pharmacol (1996) 1.09
Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid. J Neurochem (2006) 1.08
Tryptophan 121 of subunit II is the electron entry site to cytochrome-c oxidase in Paracoccus denitrificans. Involvement of a hydrophobic patch in the docking reaction. J Biol Chem (1998) 1.08
PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors. J Neurosci (2004) 1.07
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J (2000) 1.07
Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes (1999) 1.06
Identification of subtypes of [3H]prazosin-labelled alpha 1 receptor binding sites in rat brain. Eur J Pharmacol (1985) 1.06
Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp Neurol (2001) 1.06
Expression of metabotropic glutamate receptors in the rat and human testis. J Endocrinol (2001) 1.06
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. Leukemia (2008) 1.05
The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Brain Res Dev Brain Res (2004) 1.04
Transcranial magnetic stimulation after pure motor stroke. Clin Neurophysiol (2002) 1.04
L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol Pharmacol (2002) 1.04
A number of schizencephaly patients including 2 brothers are heterozygous for germline mutations in the homeobox gene EMX2. Eur J Hum Genet (1998) 1.03
Pharmacological distinction between the excitatory junctional potential and the glutamate potential revealed by concanavalin A at the crayfish neuromuscular junction. Brain Res (1979) 1.03
Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep (2005) 1.03
Growth conditions differentially regulate the expression of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor subunits in cultured neurons. J Neurochem (1993) 1.02
Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol (2000) 1.02
Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations. Neuroscience (2006) 1.02
Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition. Neurology (2006) 1.01
An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem Biophys Res Commun (1995) 1.01
The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol (1993) 1.00
Retracted Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem (2001) 1.00
Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice. Scand J Immunol (1995) 1.00
A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J Pharmacol Exp Ther (1997) 1.00